Singular Genomics Systems Inc expected to post a loss of 35 cents a share - Earnings Preview

Singular Genomics Systems

10/05/2024 21:17

* Singular Genomics Systems Inc  OMIC.OQ   OMIC.O  is
expected
to show a fall in quarterly revenue when it reports  results on
May 14 for the period ending March 31 2024
    * The San Diego California-based  company is expected to
report a
54.3% decrease in revenue to $394 thousand from $863 thousand a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Singular Genomics
Systems Inc
is for a loss of 35 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Singular
Genomics
Systems Inc is $0.85​, above​ its last closing price of $0.45.
​​​

This summary was machine generated May 10 at 20:17 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)